Coronavirus testing company, Helix has closed $50 million in a late stage funding round led by existing investors. These include Warburg Pincus, DFJ Growth, and Kleiner Perkins. Mayo Clinic and Temasek provided support as well.
Helix, also a population genomics company, enables organizations to advance research in the field. Simultaneously, the end-to-end platform allows them to accelerate the integration of related data. With the company’s innovative ‘Sequence Once, Query Often’ model, the collection, sequencing, and storage of DNA is a one-time process.
READ MORE: Indivior’s Cash Balance Yields CFR Upgrade
Founded in 2015, the company partnered with Renown Health Institute for Health Innovation (Renown HIH). Together, they sought to engage 40,000 Nevada residents in a large s…